alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Attachment 3 

Chemicals Classified as "Solids in Sdution" on EPCRA 302 List with a Vapor Pressure 

Equal to or Lower than Paraquat Dichloride 

a EPA (1 987) Technical Guidance for Hazards Analysis: Emergency Planning for Extremely Hazardous Substances, 

Report prepared by EPA, the Federal Emergency Management Agency, and the U.S. Department of Transportation, 

PB93-2069 1 0 

b If there are two numbers, the first applied to the compound in its liquid form, and the second applies to the solid form. 

Chemical Name 

Paraquat dichloride 

Paraquat methosulfate 

Arsenous oxide 

Azinphos-methyl 

Chloroxuron 

Boiling Point 

l0C) " 

None 

None 

ppp 

46S°C 

4OO0C 

None 

None 

450°C 

440°C 

None 

443OC 

Vapor Pressure (rr 

1 x lo-' 

1 x 

1 x 

1 x lo-7 

1 x lo-7 

TPQ 

 pound^)^ 

10 1 10,000 

10 1 10,000 

100 1 10,000 

10110,000 

500 1 10.OW 

100 1 10,000 

10 1 10,000 

500 1 10,000 

100 1 10,000 

100 / 10,000 

Piprotal 

Strychnine 

Strychnine, Sulfate 

Thallous ch toride 

Thallous sulfate 

Triamiphos 

Vanadium pentoide 

Zinc phosphide 

Coumaphos 

Fenamiphos 

Formetanate hydrochloride 

Phenol, 2,Z-Thiobis(4,6- 

Dichloro) 

Phenol, 2,2'-Thiobis(4- 

Chloro-6Methyl) - 

Use 

herbicide 

herbicide 

weed killer 

insecticide 

selective herbicide; 

pesticide 

insecticide 

insectrcide; nernatocide 

insecticide; acaricide 

antimicrobial agent against 

bacteria, mold, yeast; 

proposed as fungicide 

could not determine uses 

100 1 10,000 

100 1 10,000 

100 1 10,000 

100 1 10,000 

100 / 10,000 

500 / 10,000 

loo 10'000 

500 

I x 

1 x lom7 

1 x lom7 

1 x 10‘~ 

1 x lo-' 

synergist for pyrethrum 

and carbamate 

insecticides 

rodenticide 

rodenticide 

catalyst in chlorinations 

Rat poison; ant bait; 

reagent 

fungicide 

catalyst in oxidation of 

SOz to SOs; manuf. of 

yellow glass; depolarizer; 

developer in photography 

rat and field mice poison 

preparations 

1 x 10‘~ 

1 x lo4 

1 x lo4 

1 x 

1 x 10‘~ 

1 x lo-? 

1 x 1u7 

I x lo-7 

463% 

460°C 

none 

720°C 

none 

4OO0C 

I 750°C 

1 I ooOc
#### § 1210.21 Permit number.

Each permit issued under the Federal Import Milk Act, including each temporary permit, shall bear an individual number. The right to the use of such number is restricted solely to the permittee.
# EUR-Lex - 31994D0877 - EN

Avis juridique important

*|*

# 31994D0877

**94/877/EC: Commission Decision of 21 December 1994 amending Decision 93/52/EEC recording the compliance by certain Member States or regions with the requirements relating to brucellosis (B. melitensis) and according them the status of a Member State or region officially free of the disease **

*
Official Journal L 352 , 31/12/1994 P. 0102 - 0102 *

COMMISSION DECISION of 21 December 1994 amending Decision 93/52/EEC recording the compliance by certain Member States or regions with the requirements relating to brucellosis (B. melitensis) and according them the status of a Member State or region officially free of the disease (94/877/EC)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Directive 91/68/EEC of 28 January 1991 on animal health conditions governing intra-Community trade in ovine and caprine animals (1), and in particular Annex 1, Chapter 1. II thereto,

Whereas, by Decision 93/52/EEC (2), the Commission recorded the compliance by certain Member States or regions with the requirements relating to brucellosis (B. melitensis) and accorded them the status of a Member State or region officially free of the disease;

Whereas in the case of Denmark the Commission adopted in respect of brucellosis (B. melitensis) Decision 93/77/EEC (3), which is applicable until 31 December 1994;

Whereas, with effect from 1 January 1995, Denmark satisfies the prescribed conditions for it to be recognized as being officially brucellosis-free;

Whereas Denmark also undertakes to satisfy the provisions laid down in point 2 of Annex A, Chapter 1. II to Directive 91/68/EEC; whereas, therefore, Denmark should be accorded the status of a Member State officially free of brucellosis (B. melitensis), and Decision 93/52/EEC should be amended accordingly;

Whereas the measures provided for in this Decision are in accordance with the opinion of the Standing Veterinary Committee,

HAS ADOPTED THIS DECISION:

Article 1

In Annex I entitled 'MEMBER STATE' to Decision 93/52/EEC, the following line is added:

'- Denmark'.

Article 2

This Decision shall apply from 1 January 1995.

Article 3

This Decision is addressed to the Member States.

Done at Brussels, 21 December 1994.

For the Commission

René STEICHEN

Member of the Commission

(1) OJ No L 46, 19. 2. 1991, p. 19.

(2) OJ No L 13, 21. 1. 1993, p. 14.

(3) OJ No L 30, 6. 2. 1993, p. 63.
§ 1401.10 Appeal procedures. ( a ) An appeal to the ONDCP must explain the reasoning and factual basis for the appeal. It must be received by email at *FOIA@ondcp.eop.gov* or another method specified on the FOIA page of ONDCP's website within 90 days of the date of the response. The appeal must be in writing, addressed to SSDMD/RDS; ONDCP Office of General Counsel; Joint Base Anacostia-Bolling (JBAB) Bldg. 410/Door 123; 250 Murray Lane SW, Washington, DC 20509. The communication should clearly be labeled as a “Freedom of Information Act Appeal.”
( b ) The Director or designee will decide the appeal within 20 days (excepting Saturdays, Sundays, and legal public holidays). If the Director or designee deny an appeal in whole or in part, the written determination will contain the reason for the denial, the name and title of the person responsible for the denial, any FOIA exemptions applied, and the provisions for judicial review of the denial and ruling on appeal provided in 5 U.S.C. 552(a)(4). The denial will also inform the requester of the dispute resolution services offered by OGIS as a non-exclusive alternate to litigation. If ONDCP agrees to participate in voluntary dispute resolution services provided by OGIS, it will actively engage in an attempt to resolve the dispute.
#### § 1305.02 Definitions.

Any term contained in this part shall have the definition set forth in the Act or part 1300 of this chapter.
* Pursuant to 5 TH C IR . R. 47.5, the court has determined that

this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR . R. 47.5.4. United States Court of Appeals

Fifth Circuit 

## FILED November 9, 2006 Charles R. Fulbruge III Clerk IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 06-50593 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus LUIS TRINIDAD ACOSTA-SALINAS, also known as Luis Trinidad Acosta,
Defendant-Appellant.

-------------------- Appeal from the United States District Court for the Western District of Texas USDC No. 3:05-CR-2652-ALL

-------------------- Before BARKSDALE, DeMOSS, and PRADO, Circuit Judges.
PER CURIAM: * Appealing the Judgment in a Criminal Case, Luis Trinidad Acosta-Salinas raises arguments that are foreclosed by Almendarez-Torres v. United States , 523 U.S. 224, 235 (1998), which held that 8 U.S.C. § 1326(b)(2) is a penalty provision and not a separate criminal offense. The Government’s motion for summary affirmance is GRANTED, and the judgment of the district court is AFFIRMED.
exv10w4



 




Exhibit
10.4




Summary of PolyMedica Fiscal Year 2007 Bonus Plan




     On July 25, 2006, the Company’s Board of Directors (the “Board”), upon the recommendation of
the Company’s Compensation Committee, approved the performance criteria constituting the Company’s
Fiscal 2007 Bonus Plan (the “Plan”) for executive officers and other bonus-eligible employees.



     The Plan, which has not been formalized, contemplates the payment of a bonus equal to a
portion of an employee’s or executive’s base salary upon completion of certain goals and objectives
relative to the employee or executive, the overall financial performance of the Company and
satisfaction of annual compliance standards relative to the Company’s status as a Medicare
provider. The financial performance of the Company is measured by the Company’s earnings per share
and overall growth.



     For senior executives of the Company, the Plan contemplates target bonus compensation ranging
from 60% of base salary to 100% of base salary. In the event of exceptional Company financial
performance, satisfaction of an executive’s personal goals and objectives and satisfaction of the
Company’s annual compliance standards, an executive may earn as much as 130% to 200% of his or her
target bonus.



     The Plan does not create a contractual right to any bonus payments. All bonus awards are
subject to final approval by the Board, and the Board retains discretion to adjust bonus awards up
or down based upon its business judgment.
REPORT OF INDEPENDENT PUBLIC ACCOUNTANTS


      To the Board of Directors of
      Chevy Chase Bank, F.S.B.:

      We have examined management's assertion, included in the
      accompanying Management's Report on the Effectiveness of the
      Internal Control Structure Relative to the Servicing of
      Automobile Loan Receivables, that Chevy Chase Bank,
      F.S.B.(the "Bank") maintained an effective internal control
      structure over financial reporting relative to the servicing of
      automobile loan receivables owned by Chevy Chase Auto
      Receivables Trusts Series 1995-1, 1995-2 and 1996-1 (collectively
      referred to as the "Trusts" herein) as of September 30, 1997.

      Our examination was made in accordance with standards
      established by the American Institute of Certified Public
      Accountants and, accordingly, included obtaining an
      understanding of the internal control structure over financial
      reporting, testing, and evaluating the design and operating
      effectiveness of the internal control structure, and such other
      procedures as we considered necessary in the circumstances.  We
      believe that our examination provides a reasonable basis for our
      opinion.

      Because of inherent limitations in any internal control structure,
      errors or irregularities may occur and not be detected.  Also,
      projections of any evaluation of the internal control structure over
      financial reporting to future periods are subject to the risk that the
      internal control structure may become inadequate because of
      changes in conditions, or that the degree of compliance with the
      policies or procedures may deteriorate.

      In our opinion, management's assertion that the Bank maintained
      an effective internal control structure over financial reporting
      relative to the servicing of automobile receivables owned by the
      Bank's automobile loan Trusts as of September 30, 1997, is
      fairly stated, in all material respects, based upon criteria established
      in Internal Control - Integrated Framework issued by the Committee
      of Sponsoring Organizations of the Treadway Commission (COSO).

      This report is intended solely for the information and use of
      the board of directors and management of the Bank, Norwest Bank
      Minnesota, N.A., Credit Suisse, MBIA Insurance Corporation and
      Financial Guaranty Insurance Company, and should not be
      used for any other purpose.





                 Washington, D.C.
                 November 18, 1997
### Page 1 of 3 **Disposition Comments Docket No:**  

### FAA - 2011 - 132 7 These comments are in **Directorate ID:** 

### 201 1 -NM - 0 91 - AD response to an SNPRM Originating Office Tracking No.: **Next Step:** FRAN SNPRM 

### N o C omments/Only

Supportive Comments Received

– If this box is checked, no signatures are required. Yes 

### Has the reference d service information been revised since the NPRM was issued? I f ye s, lis t latest revision and attach a cop y. Note that changes beyond the scope of the previously published NPRM will require a new notice. Contact the Directorate focal point for guidance. 

### A330 - 32 - 3241 R1 and A340 - 32 - 4282 R1 Instructions: Summarize all comments **by issue** (not by commenter) and provide your recommended resolution of each issue. **All comments relating to the sam e issue should be discussed together.**  Do not list all of the issues from one commenter together. If changes to the AD are required based on the comments received, explain why and describe in detail what change(s) you recommend. Reference FAA - IR- M - 8040.1C Chapter 9. **ISSUE 1:** Select one o

f the following : If other, explain : Commenter(s): What change to the AD action is requested? Why is the change requested or how is it justified? Do we agree? If **YES,** we agree because Make the following changes to the AD: If **PARTIALLY AGREE** , we agree with because We disagree with because

Make the following changes to the AD: If **NO** , we don’t agree because **ISSUE 2**  **:** Select one of the following :

If other, explain : Commenter(s): What change to the AD action is requested? Why is the change requested or how is it justified? Do we agree? If **YES,** we agree because Make the following changes to the AD: If **PARTIALLY AGREE** , we agree w ith because We disagree with because Make the following changes to the AD:

### Page 2 of 3

If **NO** , we don’t agree because **For additional issues, do uble**  **- click**  **here**

### Page 3 of 3 **S ignature Section**  Signature indicates concurrence with this action. Originating Office Tracking No.: **ASE** Printed Name **: Date** 

**Branch M anager**  **Date**
#### § 1316.43 Information; special instructions.

Information regarding procedure under these rules and instructions supplementing these rules in special instances will be furnished by the Hearing Clerk upon request.
# m8846.docx

EUROPEAN COMMISSION Brussels, 24.4.2018 C(2018) 2644 final To the Notifying Party Subject : Case M. 8846 - Black Diamond Capital Management/GST Autoleather Commission decision pursuant to Article 6(1)(b) of Council Regulation (EC) No 139/2004 1 and Article 57 of the Agreement on the European Economic Area 2 Dear Sir or Madam, 1. On 28 March 2018 , the European Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of the Merger Regulation by which the undertaking Black Diamond Capital Management, L.L.C. ("Black Diamond", the USA), controlled by Black Diamond Capital Holdings, LLC (the USA) acquire s within the meaning of Article 3( 1)(b) of the Merger Regulation sole control over the whole of the undertaking GST Autoleather, Inc. ("GST", the USA) by way of purchase of shares . 3 2. The business activities of the undertakings concerned are: - Black Diamond is an investment advisory firm specialized in asset management, - GST is a global supplier of automotive interior leather. 3. After examination of the notification, the European Commission has concluded that the notified operation falls within the scope of the Merger Regulation and of paragraph 5 ( c ) of the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 . 4 4. For the reasons set out in the Notice on a simplified procedure, the European Commission has decided not to oppose the notified operation and to declare it compatible with the internal market and with the EEA Agreement. This decision is adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of the EEA Agreement . For the Commission
(Signed)
Johannes LAITENBERGER Director - General
(1)
OJ L 24, 29.1.2004, p. 1 ( the ' Merger Regulation ' ). With effect from 1 December 2009, the Treaty on the Functioning of the European Union ( ' TFEU ' ) has introduced certain changes, such as the replacement of ' Community ' by ' Union ' and ' common market ' by ' internal market ' . The terminology of the TFEU will be used throughout this decision.
(2) OJ L 1, 3.1.1994, p. 3 ( the ' EEA Agreement ' ).
(3) Publication in the Official Journal of the European Union No C 125 , 10 .4 . 2018 , p. 3 .
(4)
OJ C 366, 14.12.2013, p. 5 .
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>

<ARTICLE>                                              5 
<LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL
INFORMATION EXTRACTED FROM THE REGISTRANT'S FORM 10-Q FOR THE 
THREE MONTHS ENDED SEPTEMBER 30, 1996 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS INCLUDED IN
SUCH REPORT.
<RESTATED>
<CIK>
<NAME>
<MULTIPLIER>
<CURRENCY>
<FISCAL-YEAR-END>                                      DEC-31-1996
<PERIOD-START>                                         JAN-01-1996
<PERIOD-END>                                           SEP-30-1996
<PERIOD-TYPE>                                                9-MOS
<EXCHANGE-RATE>                                                                    
   
<CASH>                                                     8649002
<SECURITIES>                                                     0
<RECEIVABLES>                                                    0
<ALLOWANCES>                                                     0
<INVENTORY>                                                      0
<CURRENT-ASSETS>                                           8649002
<PP&E>                                                           0
<DEPRECIATION>                                                   0
<TOTAL-ASSETS>                                            35387770 
<CURRENT-LIABILITIES>                                       310520
<BONDS>                                                          0
<COMMON>                                                         0
<PREFERRED-MANDATORY>                                            0
<PREFERRED>                                                      0
<OTHER-SE>                                                35077250
<TOTAL-LIABILITY-AND-EQUITY>                              35387770
<SALES>                                                          0
<TOTAL-REVENUES>                                           2211643
<CGS>                                                            0
<TOTAL-COSTS>                                              1254340
<OTHER-EXPENSES>                                            353838
<LOSS-PROVISION>                                                 0
<INTEREST-EXPENSE>                                          551315
<INCOME-PRETAX>                                              52150
<INCOME-TAX>                                                 52150
<INCOME-CONTINUING>                                          52150
<DISCONTINUED>                                                   0
<EXTRAORDINARY>                                                  0
<CHANGES>                                                        0
<NET-INCOME>                                                 52150
<EPS-PRIMARY>                                                    0
<EPS-DILUTED>                                                    0


    

</TABLE>
================================================================================

                                                                      Exhibit 32



                                  CERTIFICATION
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         I, Iehab Hawatmeh, Principal Executive Officer, and I, David Harmon,
Principal Financial Officer, of CirTran Corporation (the "Company") certify
that:

         1. I have reviewed the quarterly report on Form 10-Q of the Company;

         2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
quarterly report; and

         3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
Company as of, and for, the period presented in this quarterly report.

Date:  November 14, 2008


/s/ Iehab Hawatmeh
------------------------------------------
Iehab Hawatmeh
Principal Executive Officer


/s/ David Harmon
------------------------------------------
David Harmon
Principal Financial and Accounting Officer






--------------------------------------------------------------------------------
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          MAR-31-1999
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               MAR-31-1999
<CASH>                                       6,328,191
<SECURITIES>                                         0
<RECEIVABLES>                                7,171,122
<ALLOWANCES>                                   458,157
<INVENTORY>                                  2,882,010
<CURRENT-ASSETS>                            17,699,393
<PP&E>                                      61,332,883
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              80,291,638
<CURRENT-LIABILITIES>                       15,568,902
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        45,396
<OTHER-SE>                                  43,256,856
<TOTAL-LIABILITY-AND-EQUITY>                80,291,638
<SALES>                                     52,442,520
<TOTAL-REVENUES>                            52,442,520
<CGS>                                       34,410,436
<TOTAL-COSTS>                                8,609,775
<OTHER-EXPENSES>                                16,742
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             240,602
<INCOME-PRETAX>                              8,372,579
<INCOME-TAX>                                 3,068,667
<INCOME-CONTINUING>                          5,303,912
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 5,303,912
<EPS-BASIC>                                       1.18
<EPS-DILUTED>                                     1.09


</TABLE>
#### Robert S. WHITE, Petitioner, v. Togo D. WEST, Jr., Acting Secretary of Veterans Affairs, Respondent.

No. 97-2054.

United States Court of Veterans Appeals.

Feb. 3, 1998.

Before KRAMER, FARLEY, and HOLDAWAY, Judges.

*9ORDER

PER CURIAM.

On November 12, 1997, the petitioner, through counsel, filed a petition for extraordinary relief regarding claims referred to a VA regional office (RO) by the Board of Veterans’ Appeals (BVA) in a May 15, 1997, decision. On December 10, 1997, the Secretary filed a response. The Secretary argues that the petition should be denied as moot because the petitioner died on August 9, 1997. The Court notes that in its May 15, 1997, decision, the BVA referred to an RO claims for “special monthly compensation based on loss of use of [the petitioner’s] arm and based on the need for aid and attendance,” a claim for “total evaluation based on individual unemployability due to service-connected disabilities,” and claims for “an injury to the back of the head and neck.” *Robert S. White,*BVA 95-33 760, at 2-3 (May 15, 1997).

This petition has become moot by virtue of the death of the petitioner and thus the petition must be dismissed. *See Landicho v. Brown,*7 Vet.App. 42, 47 (1994) (veterans’ disability claims under chapter 11 of title 38 of the U.S.Code do not survive their deaths). Upon consideration of the foregoing, it is

ORDERED that the petition for extraordinary relief is DISMISSED.